Consolidated Balance Sheets - USD ($)	Jun. 30, 2016	Dec. 31, 2015
Current Assets
Cash and cash equivalents	$ 17,699,686	$ 20,318,411
Accounts receivable, net of allowances of $0 at June 30, 2016 and December 31, 2015	2,892,467	2,566,101
Deferred costs	5,149,777	2,911,743
Prepaid expenses and other current assets	3,512,007	3,476,177
Total current assets	29,253,937	29,272,432
Property, plant and equipment, net	17,039,880	17,064,900
Goodwill	7,013,315	7,013,315
Intangible assets, net	2,592,880	2,877,880
Other assets	812,888	976,768
Total assets	56,712,900	57,205,295
Current Liabilities
Accounts payable	2,903,221	4,107,388
Accrued liabilities	6,202,343	6,198,488
Long-term debt, current	5,007,851	4,171,456
Notes payable, current	1,012,393	1,192,666
Unearned revenues	7,231,005	5,345,225
Total current liabilities	22,356,813	21,015,223
Long-term Liabilities
Deferred income taxes	1,032,994	932,662
Notes payable	321,375	583,041
Unearned revenues - long-term	3,812,998	0
Long-term debt	3,643,502	10,828,544
Other long-term liabilities	508,590	562,001
Total liabilities	31,676,272	33,921,471
Commitments and Contingencies (see Note 15)
Redeemable Securities	19,400,000	0
Stockholders' Equity
Preferred stock, authorized, 20,000,000 shares Series B convertible redeemable preferred stock liquidation value, 1 share of common stock, $.01 par value; 825,000 shares designated; issued and outstanding, 10,000 shares at June 30, 2016 and December 31, 2015	100	100
Common stock, $.001 par value, authorized 500,000,000 shares; issued and outstanding, 5,926,749 and 5,673,302 shares, at June 30, 2016 and December 31, 2015, respectively	5,927	5,673
Additional paid-in capital	398,699,991	396,547,401
Treasury stock, at cost; 10,999 shares at June 30, 2016 and December 31, 2015, respectively	(707,637)	(707,637)
Accumulated deficit	(391,948,123)	(372,132,490)
Accumulated other comprehensive income	0	486
Total Caladrius Biosciences, Inc. stockholders' equity	6,050,258	23,713,533
Noncontrolling interests	(413,630)	(429,709)
Total equity	5,636,628	23,283,824
Liabilities and Equity, Total	$ 56,712,900	$ 57,205,295